06667 MEGA GENOMICS
- 9.590
- +0.020+0.21%
MEGA GENOMICS News
Agency: The synthetic biology sector showed a high increase in Q1 performance, and policy expectations accelerated valuation repair
Currently, the core competitiveness of biological manufacturing companies lies in product development and implementation capabilities. They are optimistic about targets with successful cases, leading positions, high-quality product reserves, and a boom in downstream demand.
May 2 Repurchase Collection | Hang Seng Bank, Swire Group A and others bought back one after another. Of these, Hang Seng Bank spent HK$47.1617 million
According to documents disclosed by the Hong Kong Stock Exchange on May 3, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 450,000 common shares on May 2, involving an amount of HK$47.161,700. The repurchase price per share ranged from HK$105.4 to HK$102.9. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 7.984 million shares, accounting for 0.418% of the number of shares issued when the ordinary resolution was passed. ② $Taikoo
Mein Gene (06667) bought back 400 shares on May 2
Megene (06667) announced that on May 2, 2024, the company spent HK$3957.33 to return...
Repurchase Collection on April 30 | Hang Seng Bank, Swire Group A, etc. bought back one after another. Of these, Hang Seng Bank spent HK$56.2511 million
According to documents disclosed by the Hong Kong Stock Exchange on May 2, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 540,000 common shares on April 30, involving an amount of HK$56.2511 million. The repurchase price per share ranged from HK$105 to HK$103.6. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 7.534 million shares, accounting for 0.394% of the number of shares issued when the ordinary resolution was passed. ② $Taikoo Shares
MineGene (06667) spent about HK$98,900 to buy back 10,600 shares on April 30
MineGene (06667) announced that on April 30, 2024, it spent about HK$98,900 to buy back 10,600...
美因基因：年度報告2023
Repurchase Collection on April 5 | Tencent Holdings, Changshi Group, etc. bought back one after another, of which Tencent Holdings spent HK$1.03 billion
According to documents disclosed by the Hong Kong Stock Exchange on April 8, $Tencent Holdings (00700.HK) $ and $Changshi Group (01113.HK) $ repurchased shares. ① $Tencent Holdings (00700.HK) $ repurchased 3.25 million common shares on April 5, involving an amount of HK$1,003 billion. The repurchase price for each share ranged from HK$311.2 to HK$304.4. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 196 million shares, accounting for 2.043% of the number of shares issued when the ordinary resolution was passed. ② $Changshi Group (011
MineGene (06667.HK) spent HK$598,000 to buy back 64,200 shares on April 5
MineGene (06667.HK) announced that it spent HK$598,000 to repurchase 64,200 shares on April 5.
Repurchase Collection on April 2 | Tencent Holdings, HSBC Holdings, etc. repurchased one after another, of which Tencent Holdings spent HK$1 billion
According to documents disclosed by the Hong Kong Stock Exchange on April 3, $Tencent Holdings (00700.HK) $ and $HSBC Holdings (00005.HK) $ repurchased shares. ① $Tencent Holdings (00700.HK) $ repurchased 3.23 million common shares on April 2, involving an amount of HK$1 billion. The repurchase price for each share ranged from HK$311.2 to HK$308.2. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 189 million shares, accounting for 1.975% of the number of shares issued when the ordinary resolution was passed. ② $HSBC Holdings (00005.
MineGene (06667.HK) spent HK$43,800 to buy back 5,200 shares on April 2
On April 2, Gelonghui (06667.HK) announced that it spent HK$43,800 to buy back 5,200 shares on April 2.
MineGene (06667.HK) achieved annual revenue of 151 million yuan, an increase of 3.8% year-on-year
On March 26, Ge Longhui (06667.HK) announced that for the year ended December 31, 2023, the company achieved revenue of RMB 151.3 million, an increase of 3.8% over the previous year; without considering the impact of COVID-19 testing services, revenue increased 16.8% year on year. Achieved net profit of RMB 30.0 million, with a loss of RMB 17.6 million for the same period in 2022, turning a loss into a profit in 2023. Net profit increased by RMB 47.6 million compared to 2022; mainly due to the company's implementation of a more active market strategy during the reporting period to accelerate sales channels
Meiyin Gene (06667) announced its 2023 annual results, with a net profit of 30.38 million yuan, turning a year-on-year loss into a profit
MineGene (06667) announced results for the year ended December 31, 2023. The group recorded revenue of 1...
MEGA GENOMICS: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
MineGene (06667.HK) cancelled 1,224,400 shares on March 20
Gelonghui March 20 | MineGene (06667.HK) announced the cancellation of 1,224,400 shares on March 20, 2024.
MineGenomics (06667.HK) plans to hold a board meeting on March 26 to approve the annual results
Glonghui, March 14, 丨 Maingene (06667.HK) announced that the board of directors will hold a board meeting on March 26, 2024 (Tuesday) to consider and adopt the Group's annual results announcement for the year ended 31 December 2023 and its announcement, recommend a final dividend (if any), and address other matters.
MEGA GENOMICS: DATE OF BOARD MEETING
A major favorable raid, and the 1.6 trillion innovative drug sector is booming!
The advantage suddenly “smashed” into the pharmaceutical sector!
Repurchase Collection on February 23 | AIA, Kuaishou-W, etc. bought back one after another, of which AIA Insurance cost HK$110 million
According to documents disclosed by the Hong Kong Stock Exchange on February 26, $AIA (01299.HK) $, $Kuaishou-W (01024.HK) $, etc. repurchased shares. ① $AIA (01299.HK) $ repurchased 1.7 million common shares on February 23, involving an amount of HK$110 million. The repurchase price for each share ranged from HK$65.5 to HK$64.4. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 300 million shares, accounting for 2.581% of the number of shares issued when the ordinary resolution was passed. ② $Kuaishou-W (01024.HK
MineGene (06667) spent HK$2.262 million to buy back 205,400 shares on February 23
MineGene (06667) issued an announcement to repurchase 20 at HK$2.262 million on February 23, 2024...
Repurchase Collection on February 21 | AIA, Yum China, etc. bought back one after another, of which AIA Insurance cost HK$71.994,400
According to HKEx's February 22 disclosure documents, $AIA (01299.HK) $ and $Yum China (09987.HK) $ repurchased shares. ① $AIA (01299.HK) $ repurchased 1,112,200 common shares on February 21, involving an amount of HK$71.994,400. The repurchase price per share ranged from HK$65.9 to HK$63.2. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 298 million shares, accounting for 2.565% of the number of shares issued when the ordinary resolution was passed. ② $100
Analysis
Price Target
No Data
